The thymidylate synthesis cycle and anticancer drugs.
Douglas
K T
KT
Department of Pharmacy, University of Manchester, United Kingdom.
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D005472:Fluorouracil / Q000031:analogs & derivatives / Q000494:pharmacology; D012696:Glycine Hydroxymethyltransferase / Q000378:metabolism*; D008727:Methotrexate / Q000494:pharmacology; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism*; D013938:Thymidine Monophosphate / Q000096:biosynthesis*; D013940:Thymidylate Synthase / Q000378:metabolism*; D013942:Thymine Nucleotides / Q000096:biosynthesis*; D014166:Transferases / Q000378:metabolism*
D000970:Antineoplastic Agents; D013942:Thymine Nucleotides; D013938:Thymidine Monophosphate; D013762:Tetrahydrofolate Dehydrogenase; D014166:Transferases; D013940:Thymidylate Synthase; D012696:Glycine Hydroxymethyltransferase; D005472:Fluorouracil; D008727:Methotrexate